Company Filing History:
1 out of 73 
1 out of 1,311 
1 out of 17 
Years Active: 2025
Title: Christine Sturm: Innovator in Cancer Treatment
Introduction
Christine Sturm is a notable inventor based in Homburg, Germany. She has made significant contributions to the field of cancer research, particularly through her innovative approaches to targeting cancer cells.
Latest Patents
Christine Sturm holds a patent for "Methods and composition for a binding molecule targeting cancer cells expressing SSX2 peptide 41-49 in HLA-A*0201 context." This patent discloses binding molecules related to Synovial Sarcoma X breakpoint 2 and outlines methods for their use in the detection and treatment of cancer. Her work represents a crucial advancement in cancer therapeutics.
Career Highlights
Throughout her career, Christine has worked with prestigious institutions such as Children's National Medical Center and Washington University. Her experience in these organizations has allowed her to develop and refine her innovative ideas in cancer treatment.
Collaborations
Christine has collaborated with esteemed colleagues, including Eric Yvon and Catherine M. Bollard. These partnerships have further enhanced her research and contributions to the field.
Conclusion
Christine Sturm's work exemplifies the impact of innovation in medical science, particularly in the fight against cancer. Her dedication to developing targeted therapies showcases the potential of scientific research to improve patient outcomes.